ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

California Cancer Research Program Seeks Non-Resident Survivor Reviewers.

May 25, 2001

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Congress Approves FY 2010 Budget. Loehrer Named Interim Director At Indiana

April 10, 2009